Daron G. Street

There's a new way to fight it, said Dr. Daron Street, an oncologist with Cancer Care Associates."There are now two vaccines out that are preventative," Street said.
...
"Probably most sexually active people have been exposed," said Dr. Street."Some people are able to clear the virus, but there's no way to know."Yearly Pap exams are important for women because the virus can often be identiied early at this time."Yearly screening saves a huge number of lives," Dr. Street said."Until AIDS came on the scene, cervical cancer was the No. 1 killer of reproductive age women."Without regular screening cervical cancer is virtually undetectable until it is too late."It's not painful, and bleeding only starts when it's large," Dr. Street said.
...
"That's ludicrous," Dr. Street said.
...
Street is amazed at the advances made and is optimistic at what the future holds."I hope to see more therapeutic vaccines in the next three years," he said.

Daron G. Street, M.D.
...
Dr. Street graduated from Southern Nazarene University and received a medical degree from the University of Oklahoma College of Medicine in Tulsa.His post-graduate training in obstetrics and gynecology included a four-year residency at the University of Oklahoma College of Medicine and a three-year gynecologic oncology fellowship at Loyola University Medical Center in Maywood, Illinois.Dr. Street served as a clinical instructor for the department of obstetrics and gynecology at Loyola University Medical Center and as assistant professor and director of gynecologic oncology at the University of Oklahoma College of Medicine in Tulsa.He is a fellow of the American College of Obstetrics and Gynecology and board certified in obstetrics and gynecology.Dr. Street participated in a one-year cervical cancer research study and has given lectures and co-authored several papers on cervical cancer.

Daron G. Street, M.D.
...
Daron G. Street , M.D.
...
Dr. Street graduated from Southern Nazarene University and received a medical degree from the University of Oklahoma College of Medicine in Tulsa.His post-graduate training in obstetrics and gynecology included a four-year residency at the University of Oklahoma College of Medicine and a three-year gynecologic oncology fellowship at Loyola University Medical Center in Maywood, Illinois.Dr. Street served as a clinical instructor for the department of obstetrics and gynecology at Loyola University Medical Center and as assistant professor and director of gynecologic oncology at the University of Oklahoma College of Medicine in Tulsa.He is a fellow of the American College of Obstetrics and Gynecology and board certified in obstetrics and gynecology.Dr. Street participated in a one-year cervical cancer research study and has given lectures and co-authored several papers on cervical cancer.

There's a new way to fight it, said Dr. Daron Street, an oncologist with Cancer Care Associates. "There are now two vaccines out that are preventative," Street said.
...
"Probably most sexually active people have been exposed," said Dr. Street. "Some people are able to clear the virus, but there's no way to know. "Yearly Pap exams are important for women because the virus can often be identiied early at this time. "Yearly screening saves a huge number of lives," Dr. Street said. "Until AIDS came on the scene, cervical cancer was the No. 1 killer of reproductive age women. "Without regular screening cervical cancer is virtually undetectable until it is too late. "It's not painful, and bleeding only starts when it's large," Dr. Street said.
...
"That's ludicrous," Dr. Street said.
...
"Dr. Street is amazed at the advances made and is optimistic at what the future holds. "I hope to see more therapeutic vaccines in the next three years," he said.

Daron G. Street
...
Daron G. Street MD, FACOG

Daron G. Street, MD, FACOG

Dr. Street graduated from Southern Nazarene University and received a medical degree from the University of Oklahoma College of Medicine in Tulsa. His post-graduate training in Obstetrics and Gynecology included a four-year residency at the University of Oklahoma College of Medicine and a three-year Gynecologic oncology fellowship at Loyola University Medical Center in Maywood, Illinois.

Dr. Street served as a clinical instructor for the department of Obstetrics and Gynecology at Loyola University Medical Center and as assistant professor and director of Gynecologic Oncology at the University of Oklahoma College of Medicine in Tulsa. He is a fellow of the American College of Obstetrics and Gynecology and is board certified in Obstetrics and Gynecology. Dr. Street participated in a one-year cervical cancer research study and has given lectures and co-authored several papers on cervical cancer.

There's a new way to fight it, said Dr. Daron Street, an oncologist with Cancer Care Associates. "There are now two vaccines out that are preventative," Street said. Cervical cancer is related to a virus. Medical advances have created an immunization that can fight against HPV - the primary cause of most cervical cancers. The vaccines, approved last year, can protect women from developing precancerous lesions in the cervix, vulva and vagina. HPV is the human papillomavirus, and it is a very common sexually transmitted disease. "Probably most sexually active people have been exposed," said Dr. Street. "Some people are able to clear the virus, but there's no way to know. "Yearly Pap exams are important for women because the virus can often be identiied early at this time. "Yearly screening saves a huge number of lives," Dr. Street said. "Until AIDS came on the scene, cervical cancer was the No. 1 killer of reproductive age women. "Without regular screening cervical cancer is virtually undetectable until it is too late. "It's not painful, and bleeding only starts when it's large," Dr. Street said.
...
"That's ludicrous," Dr. Street said.
...
"Dr. Street is amazed at the advances made and is optimistic at what the future holds. "I hope to see more therapeutic vaccines in the next three years," he said.

"It's a hard disease to diagnose," said Dr. Daron Street, a gynecologic oncologist with Cancer Care Associates in Tulsa."There's enough room in the abdomen that (tumors) can get quite large before a person knows it."

Women with ovarian cancer often experience symptoms such as gas, bloating, abdominal distention, shortness of breath, a feeling of fullness after eating a very small amount of food or bladder symptoms such as frequent urination, Street said.

These nonspecific symptoms are frequently diagnosed as other conditions.When they worsen or fail to get better with treatment, additional testing may be required to rule out ovarian cancer.

A combination of tests is often used to diagnose ovarian cancer, Street said.Among the tests used are a complete pelvic exam, an ultrasound of the pelvic region, a CT scan (a computerized X-ray test that produces cross-sectional images of the body and can reveal disease or abnormalities in tissue and bone) and a CA-125 blood test.

While the CA-125, which measures blood levels of a protein shed by cancer cells, is frequently cited as one of the top detection methods for ovarian cancer, it is not always reliable, Street said.
...
Ovarian cancer is primarily a disease of older, usually post-menopausal women, but younger women occasionally develop it -- the late comedienne Gilda Radner was in her late 30s when diagnosed with the disease -- and those who have a familial predisposition often develop ovarian cancer 10 to 15 years earlier than the general population, Street said.
...
Surgery to remove ovarian cancer tumors is commonly referred to as "debulking," because it attempts to remove the majority or bulk of the disease, Street said.
...
Surviving ovarian cancer depends on many factors, Street said.The stage and grade of a patient's disease, how much of the tumor can be removed during surgery, how well chemotherapy works and just plain luck all affect the outcome.

Ninety percent to 95 percent of ovarian cancer patients whose disease is detected before it has spread outside the ovaries, will celebrate their five-year-survival mark.But only about a quarter of all ovarian cancers are found at this early stage.

Survival rate is even lower in women who have had a recurrence of the disease, Street said.